Helixmith Announces First Patient Enrolled in Phase 3 Study of... Posted By: Anonymous | Posted On: Nov 19,2020 00:00 am | View: 59 Helixmith announced today enrollment of the first patient in a second Phase 3 clinical trial targeting diabetic peripheral neuropathy (DPN), REGAiN-1A, using Helixmith’s flagship gene therapy product... read more ...
American and Frenchman Turning Pro with Team Novo Nordisk Posted By: Anonymous | Posted On: Nov 12,2020 12:00 pm | View: 66 Team Novo Nordisk, the world’s first all-diabetes professional cycling team, brings up two of its best development riders, American Logan Phippen and Frenchman Lucas Dauge, onto the men’s pro squad... read more ...
American College of Lifestyle Medicine Launches Bill of Rights to... Posted By: Anonymous | Posted On: Nov 12,2020 00:00 am | View: 53 With a goal of patient empowerment, the American College of Lifestyle Medicine has announced a Type 2 Diabetes Bill of Rights campaign to raise consumer awareness regarding patient rights to... read more ...
PercuSense Announces Project with the University of Melbourne funded... Posted By: Anonymous | Posted On: Nov 03,2020 00:00 am | View: 87 By combining glucose and ketone on a single implantable sensor, PercuSense aims to reduce the risk of diabetic ketoacidosis, reducing the burden and ultimately increasing the treatment options for... read more ...
Disclaimer: Issuers of the submissions/postings are solely responsible for the content of their submissions. Doctorsoutlook.com can't be held liable for the contents of these submissions. In case any submission damages your benefits or violate your rights in any way, please contact us and we'll remove it immediately.
